Table 2.
Groups | Control | BSF | P value |
---|---|---|---|
Sample size | 39 | 40 | — |
Female sex (%)a | 20 (51.3%) | 18 (45.0%) | >0.05 |
Age (years)b | 62.95 ± 7.24 | 63.35 ± 8.02 | >0.05 |
HbA1c (%)b (week 0) | 7.81 ± 1.67 | 7.96 ± 1.40 | >0.05 |
HbA1c (%)b (week 12) | 6.47 ± 1.92 | 6.46 ± 0.74 | >0.05 |
Total cholesterol (mmol/l)b (week 0) | 6.04 ± 1.45 | 5.87 ± 1.14 | >0.05 |
Total cholesterol (mmol/l)b (week 12) | 4.59 ± 0.90 | 4.44 ± 0.87 | >0.05 |
Triglyceride (mmol/l)b (week 0) | 2.31 ± 0.89 | 2.29 ± 0.93 | >0.05 |
Triglyceride (mmol/l)b (week 12) | 1.64 ± 0.45 | 1.54 ± 0.38 | >0.05 |
Serum albumin (g/l)b (week 0) | 28.6 ± 1.4 | 28.3 ± 1.7 | >0.05 |
Serum albumin (g/l)b (week 12) | 33.2 ± 2.7 | 38.0 ± 2.4 | <0.05 |
Serum creatinine (μmol/l)b (week 0) | 121.6 ± 10.1 | 124.6 ± 13.0 | >0.05 |
Serum creatinine (μmol/l)b (week 12) | 115.6 ± 10.1 | 94.9 ± 13.0 | <0.05 |
Blood urea nitrogen (mmol/l)b (week 0) | 7.5 ± 0.4 | 7.6 ± 0.7 | >0.05 |
Blood urea nitrogen (mmol/l)b (week 12) | 6.7 ± 0.5 | 5.6 ± 0.3 | <0.05 |
24 h urinary protein (g)b (week 0) | 3.4 ± 1.9 | 3.48 ± 2.1 | >0.05 |
24 h urinary protein (g)b (week 12) | 3.18 ± 1.94 | 2.55 ± 1.67 | <0.05 |
aThe data are expressed as counts (%), and the P value for the between-group difference is calculated from the Wilcoxon rank sum test. bThe data are expressed as the mean ± S.E.M., and the P value for the two group comparisons is calculated using an independent-sample t-test.